Academician
ELİF GÜLER
PROFESÖR
AKDENİZ ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Çocuk Hematolojisi ve Onkolojisi (Çocuk Sağlığı ve Hastalıkları)
Article counts come from two sources, each shown separately: YÖKSİS (academic declarations) and OpenAlex (open scholarly catalog). Patents and artistic activities are listed under the Works tabs below.
Index quartiles
Scopus (SJR)
41 Total
- Q1 12
- Q2 13
- Q3 12
- Q4 4
Other counts
- Excluding abstracts 36 Q1 7 Q2 13 Q3 12 Q4 4
- YÖKSİS rows 41 Q1 0 Q2 0 Q3 0 Q4 0
WoS (JCR)
44 Total
- Q1 9
- Q2 10
- Q3 4
- Q4 21
Other counts
- Excluding abstracts 39 Q1 4 Q2 10 Q3 4 Q4 21
- YÖKSİS rows 44 Q1 0 Q2 0 Q3 0 Q4 0
TR Index
6 articles
OpenAlex citation percentiles
Top 1% articles
0
Top 10% articles
0
Avg percentile
48.4%
Articles with percentile
10
OpenAlex citation percentile; covered works only (~52%).
What do these indicators mean?
- Q1–Q4: the quartile of the journal in the given index (Scopus/WoS). Q1 = top 25%, Q4 = bottom 25%.
- Top 1% / top 10%: number of works among the top 1% or 10% most-cited worldwide in the same field and year.
- Avg percentile: mean citation percentile of the works (100 = highest).
- Source: index quartiles from Scopus/WoS and TR Index flags; citation percentiles from OpenAlex.
Proceedings
Conference proceedings recorded in YÖKSİS.
Records
- 2020 Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Intermediate Risk Group Treatment Results.
- 2020 Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol High Risk Group Treatment Results
- 2018 TPOG Nöroblastom 2009 protokolu: Yüksek risk grubu-otolog kök hücre transplantasyonu tedavi kolu güncel ön sonuçları
- 2019 TREATMENT OF NEUROBLASTOMA IN INFANTS YOUNGER THAN 18 MONTHS WITH THE TPOG NEUROBLASTOMA TREATMENT PROTOCOL ON BEHALF OF THE TURKISH PEDIATRIC ONCOLOGY GROUP
- 2019 Türk Pediatrik Onkoloji Grubu Adına Ganglionörom Tanılı Hastaların DeğerlendirilmesiI
- 2020 Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Low Risk Group Treatment Results.
- 2018 TPOG-NBL 2009 Protokolü, Yüksek Risk Grubu Otolog Kök Hücre Transplantasyonu Kolu güncel sonuçları
- 2018 TPOG-Nöroblastom 2009 Protokolü: Yüksek Risk Grubu-Otolog Kök Hücre Transplantasyonu Tedavi Kolu Güncel ön Sonuçları
- 2018 Akut lösemili çocuklarda allojenik hematopoietik kök hücre nakli sonrasındaki relapsta tedavi yaklaşımları
- 2020 Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Low Risk Group Treatment Results52th Congress of the International Society of Paediatric
- 2019 Ganglioneuroma Experience of the TPOG Neuroblastoma 2003 and 2009 Treatment Protocols On Behalf of the Turkish Pediatric Oncology Group
- 2018 Akut lösemili çocuklarda allojenik hematopoetik kök hücre nakli sonrasındarelpsda tedavi yaklaşımları
- 2018 PTLD OF CENTRAL NERVOUS SYSTEM: A FATAL COMPLICATION AFTER RENAL TRANSPLANTATION
- 2018 TPOG NÖROBLASTOMA 2009 PROTOKOL YÜKSEK RİSK GRUBU OYOLOG KÖK HÜCRE TEDAVİ KOLU GÜNCEL SONUÇLAR
- 2018 Relapse after allogeneic hematopoietic stem cell transplantation for acute leukemıa in children: a survey by theTurkish pediatricbone marrow study group of 225 cases.
- Experience of two centers’xx histopathological and immunhistochemical characteristics of Hodgkin’xxs lymphomas in mediterranean Turkey
- 2020 Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Low Risk Group Treatment Results
- 2020 Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Low Risk Group Treatment Results52th Congress of the International Society of Paediatric
- 2017 Effectivity of defibrotide prophylaxis on acute graft versus host disease: a single center experience with high risk pediatric patientsBy:Yalcin, K (Yalcin, K.)[ 1 ] Guler, E (Guler, E.)[ 1 ] Kupesiz, A (Kupesiz, A.)[ 1 ]BONE MARROW TRANSPLANTATIONVolume: 52 Pages: S357-S358 Supplement: 1 Meeting Abstract: P457Published: JUL 2017Document Type:Meeting AbstractView Journal Impact
- 2017 Treatment of a Hepatoblastoma in a 1 year old boy by intraoperative ultrasound guided radiofrequency ablation with 3 years follow up.